These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20447400)

  • 21. Bile acids acutely stimulate insulin secretion of mouse β-cells via farnesoid X receptor activation and K(ATP) channel inhibition.
    Düfer M; Hörth K; Wagner R; Schittenhelm B; Prowald S; Wagner TF; Oberwinkler J; Lukowski R; Gonzalez FJ; Krippeit-Drews P; Drews G
    Diabetes; 2012 Jun; 61(6):1479-89. PubMed ID: 22492528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions between Atorvastatin and the Farnesoid X Receptor Impair Insulinotropic Effects of Bile Acids and Modulate Diabetogenic Risk.
    Hoffmeister T; Kaiser J; Lüdtke S; Drews G; Düfer M
    Mol Pharmacol; 2020 Mar; 97(3):202-211. PubMed ID: 31911428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Farnesoid X receptor agonists attenuate colonic epithelial secretory function and prevent experimental diarrhoea in vivo.
    Mroz MS; Keating N; Ward JB; Sarker R; Amu S; Aviello G; Donowitz M; Fallon PG; Keely SJ
    Gut; 2014 May; 63(5):808-17. PubMed ID: 23916961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nuclear bile acid receptor FXR controls the liver derived tumor suppressor histidine-rich glycoprotein.
    Deuschle U; Birkel M; Hambruch E; Hornberger M; Kinzel O; Perović-Ottstadt S; Schulz A; Hahn U; Burnet M; Kremoser C
    Int J Cancer; 2015 Jun; 136(11):2693-704. PubMed ID: 25363753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Palmitic acid-rich diet suppresses glucose-stimulated insulin secretion (GSIS) and induces endoplasmic reticulum (ER) stress in pancreatic islets in mice.
    Hirata T; Kawai T; Hirose H; Tanaka K; Kurosawa H; Fujii C; Fujita H; Seto Y; Matsumoto H; Itoh H
    Endocr Res; 2016; 41(1):8-15. PubMed ID: 26167855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The significance of the nuclear farnesoid X receptor (FXR) in β cell function.
    Düfer M; Hörth K; Krippeit-Drews P; Drews G
    Islets; 2012; 4(5):333-8. PubMed ID: 23073079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible involvement of A₂A and A₃ receptors in modulation of insulin secretion and β-cell survival in mouse pancreatic islets.
    Ohtani M; Oka T; Ohura K
    Gen Comp Endocrinol; 2013 Jun; 187():86-94. PubMed ID: 23453966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FXR Mediates Adenylyl Cyclase 8 Expression in Pancreatic
    Kong X; Li B; Deng Y; Ma X
    J Diabetes Res; 2019; 2019():8915818. PubMed ID: 31485455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation and functional effects of ZNT8 in human pancreatic islets.
    Lefebvre B; Vandewalle B; Balavoine AS; Queniat G; Moerman E; Vantyghem MC; Le Bacquer O; Gmyr V; Pawlowski V; Kerr-Conte J; Pattou F
    J Endocrinol; 2012 Aug; 214(2):225-32. PubMed ID: 22582094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The bile acid sensor FXR regulates insulin transcription and secretion.
    Renga B; Mencarelli A; Vavassori P; Brancaleone V; Fiorucci S
    Biochim Biophys Acta; 2010 Mar; 1802(3):363-72. PubMed ID: 20060466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model.
    Deuschle U; Schüler J; Schulz A; Schlüter T; Kinzel O; Abel U; Kremoser C
    PLoS One; 2012; 7(10):e43044. PubMed ID: 23056173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ARHGAP21 prevents abnormal insulin release through actin rearrangement in pancreatic islets from neonatal mice.
    Ferreira SM; Santos GJ; Rezende LF; Gonçalves LM; Santos-Silva JC; Bigarella CL; Carneiro EM; Saad ST; Boschero AC; Barbosa-Sampaio HC
    Life Sci; 2015 Apr; 127():53-8. PubMed ID: 25744409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of chemerin as a novel FXR target gene down-regulated in the progression of nonalcoholic steatohepatitis.
    Deng Y; Wang H; Lu Y; Liu S; Zhang Q; Huang J; Zhu R; Yang J; Zhang R; Zhang D; Shen W; Ning G; Yang Y
    Endocrinology; 2013 May; 154(5):1794-801. PubMed ID: 23507574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction.
    Jiang C; Xie C; Lv Y; Li J; Krausz KW; Shi J; Brocker CN; Desai D; Amin SG; Bisson WH; Liu Y; Gavrilova O; Patterson AD; Gonzalez FJ
    Nat Commun; 2015 Dec; 6():10166. PubMed ID: 26670557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal model.
    Han SY; Song HK; Cha JJ; Han JY; Kang YS; Cha DR
    Acta Diabetol; 2021 Apr; 58(4):495-503. PubMed ID: 33399988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformationally constrained farnesoid X receptor (FXR) agonists: alternative replacements of the stilbene.
    Akwabi-Ameyaw A; Caravella JA; Chen L; Creech KL; Deaton DN; Madauss KP; Marr HB; Miller AB; Navas F; Parks DJ; Spearing PK; Todd D; Williams SP; Wisely GB
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6154-60. PubMed ID: 21890356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) agonists to improve physicochemical and ADME properties.
    Richter HG; Benson GM; Bleicher KH; Blum D; Chaput E; Clemann N; Feng S; Gardes C; Grether U; Hartman P; Kuhn B; Martin RE; Plancher JM; Rudolph MG; Schuler F; Taylor S
    Bioorg Med Chem Lett; 2011 Feb; 21(4):1134-40. PubMed ID: 21269824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of early biological changes in palmitate-treated isolated human islets.
    Sargsyan E; Cen J; Roomp K; Schneider R; Bergsten P
    BMC Genomics; 2018 Aug; 19(1):629. PubMed ID: 30134843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IFN-γ secretion in gut of Ob/Ob mice after vertical sleeve gastrectomy and its function in weight loss mechanism.
    Du JP; Wang G; Hu CJ; Wang QB; Li HQ; Xia WF; Shuai XM; Tao KX; Wang GB; Xia ZF
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):377-382. PubMed ID: 27376807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and pharmacological validation of a novel series of non-steroidal FXR agonists.
    Abel U; Schlüter T; Schulz A; Hambruch E; Steeneck C; Hornberger M; Hoffmann T; Perović-Ottstadt S; Kinzel O; Burnet M; Deuschle U; Kremoser C
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4911-7. PubMed ID: 20638278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.